Canadian government almost swamped by ciprofloxacinBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7320.1026/c (Published 03 November 2001) Cite this as: BMJ 2001;323:1026
- David Spurgeon
Canada's federal government has narrowly avoided having to pay for twice as much of the antibiotic ciprofloxacin (Cipro) as it thinks it needs to protect its citizens in the case of an outbreak of anthrax.
The federal health department circumvented its own drug patent rules when it ordered about 900 000 tablets of the medication from a generic drug manufacturer, Apotex. The patent, held by Bayer AG, does …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial